Insulin-Like Growth Factor 1 (IGF1) Peptid
IGF1
Wirt: Synthetic
BP, WB, IHC
-
- Target Alle IGF1 Produkte
- IGF1 (Insulin-Like Growth Factor 1 (IGF1))
-
Quelle
- Synthetic
- Applikation
- Blocking Peptide (BP), Western Blotting (WB), Immunohistochemistry (IHC)
- Verwendungszweck
- Insulin Like Growth Factor 1, Insulin-Like Growth Factor I, IGF-I, Somatomedin-C
- Sequenz
- Peptide (C)NKPTGYGSSI RR, correspond ing to amino acid residues 74 - 85 of rat IGF1 (Accession P08025).
- Produktmerkmale
- A Blocking peptide for Anti-IGF1 Antibody (#ABIN7237701).
- Reinheit
- >70 %
-
Insulin-Like Growth Factor 1 (IGF1) (AA 81-96) peptide (Ovalbumin)
IGF1 Reaktivität: Human Wirt: Synthetic Imm, WB, SDS
-
- Applikationshinweise
- Antigen Preadsorption Control: 1 μg peptide per 1 μg antibody.
- Kommentare
-
Confirmed by amino acid analysis and mass spectrometry.
- Beschränkungen
- Nur für Forschungszwecke einsetzbar
-
- Format
- Lyophilized
- Rekonstitution
- 100 μL double distilled water (DDW).
- Konzentration
- 0.4 mg/mL
- Lagerung
- RT,-20 °C
- Informationen zur Lagerung
- Lyophilized powder can be stored intact at room temperature for two weeks. For longer periods, it should be stored at -20°C.
-
- Target
- IGF1 (Insulin-Like Growth Factor 1 (IGF1))
-
Sie sind hier:
